Sandy

rescheduling delayed

DEA mentions plans to begin rescheduling of cannabis after the election

The DEA’s Rescheduling Plans: A Game Changer for the Cannabis Industry? The DEA plans to start rescheduling cannabis after the election, and this decision could be monumental for the cannabis industry. With a long-standing classification as a Schedule I drug, marijuana has faced stringent federal restrictions that have stifled growth…
Read More
ny cannabis growth

NY state cannabis tax revenue is increasing

NY Cannabis Industry Growth Adult-use cannabis taxation and revenue in New York State are on the rise. This growing tax revenue is proving to be a significant boost to the state’s economy. Legal adult-use cannabis sales have created a thriving market that supports local economies and combats illegal marijuana sales.…
Read More
texas cannabis

Texas voters want cannabis decriminalized

Texans seem to want to legalize cannabis Texas voters want cannabis decriminalized, and the momentum is undeniable. Over the past few years, there has been a significant push towards reforming marijuana laws in Texas. The movement is largely driven by local voter initiatives that are reshaping how cannabis is perceived…
Read More
louisiana cannabis tax

Louisiana collected nearly 1M in cannabis revenue tax

State and Federal Taxes on Cannabis in Louisiana Louisiana’s cannabis income tax landscape has seen significant developments in recent years. The state’s approach to cannabis tax revenue, particularly from medical marijuana, has become a noteworthy facet of its economic framework. Medical marijuana legalization in Louisiana, which has been in effect…
Read More

Rescheduling Cannabis and Its Broad Ripple Effects Part 6

Beyond Legislation: The Societal Shifts in Health, Housing, and Employment from Cannabis Rescheduling Welcome to the concluding part of our series, “The New Frontier: Rescheduling Cannabis and Its Broad Ripple Effects.” In this final installment, we examine the rescheduling of cannabis through a societal lens, focusing on its impacts on…
Read More

Rescheduling Cannabis and Its Broad Ripple Effects Part 5

Corporate Giants Enter the Arena: Navigating New Economic Challenges in Cannabis Welcome to Part 5 of our comprehensive series, “The New Frontier: Rescheduling Cannabis and Its Broad Ripple Effects.” This installment explores the intricate economic shifts and corporate dynamics unleashed by the rescheduling of cannabis to Schedule III. We examine…
Read More

Rescheduling Cannabis and It’s Broad Ripple Effect Part 4

Rescheduling Cannabis and Its Broad Ripple Effect: Legal Complexities in a New Era of Cannabis Policy Welcome to Part 4 of our enlightening series on the transformative rescheduling of cannabis. As we navigate through the newly charted territories, this installment delves into the intricate legal complexities that accompany the transition…
Read More
rescheduling cannabis

Rescheduling Cannabis and Its Broad Ripple Effects Part 3

Part 3: Harnessing R&D Tax Credit Opportunities Post-Rescheduling Continuing our exploration in Part 3 of “The New Frontier: Rescheduling Cannabis and Its Broad Ripple Effects,” we shift our focus to the Research & Development (R&D) Tax Credit Opportunities that have opened up for the cannabis industry. Research and Development Credit…
Read More

Rescheduling Cannabis and Its Broad Ripple Effects Part 2

Welcome to Part II of our comprehensive series, “The New Frontier: Rescheduling Cannabis and Its Broad Ripple Effects.” In this installment, we explore the significant tax implications resulting from the DEA’s decision to reclassify cannabis as a Schedule III substance. This reclassification ushers in a new fiscal environment for cannabis…
Read More

We understand the importance of approaching each work integrally and believe in the power of simple.

Melbourne, Australia
(Sat - Thursday)
(10am - 05 pm)